** Shares of Amplia Therapeutics ATX.AX fall 3.6% to A$0.135, on track for their weakest session since November 18** The clinical-stage, drug development co's HY loss attributable widens to A$4.2 million ($2.75 million) from A$2.8 million last year** However, ATX up 21.7% this week, set for its strongest week since July 10** Stock up 51.7% YTD

($1 = 1.5300 Australian dollars)

(Reporting by Jasmeen Ara Shaikh in Bengaluru)

((Jasmeenaraislam.shaikh@thomsonreuters.com ))